MF
AEON.WS

Magnetar Financial’s AEON Biopharma Inc AEON.WS Stock Holding History

Magnetar Financial’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-61,159
Closed -$5K – 1091
2022
Q3 		$5K Buy
61,159
+1,427
+2% +$130 ﹤0.01% 1245
2022
Q2 		$9 Buy
+59,732
New +$12.6K ﹤0.01% 1440

Other funds holding AEON.WS

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Magnetar Financial's AEON.WS Position: Q4 2022 in Review

Magnetar Financial sold out of AEON Biopharma Inc (AEON.WS) in Q4 2022, closing a stake of 61,159 shares — an estimated $5K sold.

Magnetar Financial first reported a position in AEON.WS in Q2 2022 and held it in 2 quarters. The position peaked at $5K in Q3 2022. 52 funds tracked by Wall St. Rank hold AEON.WS as of Q4 2022.

  • Magnetar Financial reported no remaining AEON Biopharma Inc position as of Q4 2022 after selling out during the quarter.
  • Magnetar Financial sold 61,159 AEON Biopharma Inc shares in Q4 2022, an estimated $5K.
  • Magnetar Financial first reported a position in AEON Biopharma Inc in Q2 2022 and held it in 2 quarters.
  • Magnetar Financial's AEON Biopharma Inc position peaked at $5K in Q3 2022.
  • 52 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q4 2022.

Based on Magnetar Financial's 13F filing for Q4 2022, filed 14 Feb 2023.